143 related articles for article (PubMed ID: 27094303)
1. Development of a credible 3D-QSAR CoMSIA model and docking studies for a series of triazoles and tetrazoles containing 11β-HSD1 inhibitors.
Murumkar PR; Shinde AC; Sharma MK; Yamaguchi H; Miniyar PB; Yadav MR
SAR QSAR Environ Res; 2016 Apr; 27(4):265-92. PubMed ID: 27094303
[TBL] [Abstract][Full Text] [Related]
2. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors.
Lee JH; Kang NS; Yoo SE
Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
Ye XY; Yoon D; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Apedo A; Li YX; He B; Kirby M; Gordon DA; Robl JA
Bioorg Med Chem Lett; 2014 Jan; 24(2):654-60. PubMed ID: 24360604
[TBL] [Abstract][Full Text] [Related]
5. Structural Insights and Docking Analysis of Adamantane-Linked 1,2,4-Triazole Derivatives as Potential 11β-HSD1 Inhibitors.
Osman DA; Macías MA; Al-Wahaibi LH; Al-Shaalan NH; Zondagh LS; Joubert J; Garcia-Granda S; El-Emam AA
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500764
[TBL] [Abstract][Full Text] [Related]
6. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
[TBL] [Abstract][Full Text] [Related]
7. Modulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles.
Webster SP; Binnie M; McConnell KM; Sooy K; Ward P; Greaney MF; Vinter A; Pallin TD; Dyke HJ; Gill MI; Warner I; Seckl JR; Walker BR
Bioorg Med Chem Lett; 2010 Jun; 20(11):3265-71. PubMed ID: 20452767
[TBL] [Abstract][Full Text] [Related]
8. Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
Tu H; Powers JP; Liu J; Ursu S; Sudom A; Yan X; Xu H; Meininger D; Degraffenreid M; He X; Jaen JC; Sun D; Labelle M; Yamamoto H; Shan B; Walker NP; Wang Z
Bioorg Med Chem; 2008 Oct; 16(19):8922-31. PubMed ID: 18789704
[TBL] [Abstract][Full Text] [Related]
9. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice.
Zhao L; Pan Y; Peng K; Wang Z; Li J; Li D; Tong C; Wang Y; Liang G
J Mol Endocrinol; 2015 Oct; 55(2):119-31. PubMed ID: 26220348
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
Yang H; Dou W; Lou J; Leng Y; Shen J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087
[TBL] [Abstract][Full Text] [Related]
12. Novel 2-(Adamantan-1-ylamino)Thiazol-4(5
Studzińska R; Kupczyk D; Płaziński W; Baumgart S; Bilski R; Paprocka R; Kołodziejska R
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445315
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Chaube U; Bhatt H
Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
[TBL] [Abstract][Full Text] [Related]
14. A novel derivatives of thiazol-4(5H)-one and their activity in the inhibition of 11β-hydroxysteroid dehydrogenase type 1.
Studzińska R; Kołodziejska R; Kupczyk D; Płaziński W; Kosmalski T
Bioorg Chem; 2018 Sep; 79():115-121. PubMed ID: 29738970
[TBL] [Abstract][Full Text] [Related]
15. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499.
Byun SY; Shin YJ; Nam KY; Hong SP; Ahn SK
Life Sci; 2015 Jan; 120():1-7. PubMed ID: 25447448
[TBL] [Abstract][Full Text] [Related]
16. Molecular Modeling Studies of 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors through Receptor-Based 3D-QSAR and Molecular Dynamics Simulations.
Qian H; Chen J; Pan Y; Chen J
Molecules; 2016 Sep; 21(9):. PubMed ID: 27657020
[TBL] [Abstract][Full Text] [Related]
17. Distinct inhibitory strength of bisphenol A analogues on human and rat 11β-hydroxysteroid dehydrogenase 1: 3D quantitative structure-activity relationship and in silico molecular docking analysis.
Lu H; Wang S; Zheng J; Zhu Y; Wang Y; Li H; Ge RS
Ecotoxicol Environ Saf; 2023 Nov; 267():115638. PubMed ID: 37918333
[TBL] [Abstract][Full Text] [Related]
18. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
Su X; Vicker N; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
Mol Cell Endocrinol; 2006 Mar; 248(1-2):214-7. PubMed ID: 16325333
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of 1,4-diaryl-1,4-dihydropyrazines as novel 11β-HSD1 inhibitors.
Duan X; Xin H; Yan H
Biol Pharm Bull; 2014; 37(5):840-6. PubMed ID: 24790006
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, molecular docking and in vitro evaluation of benzothiazole derivatives as 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
Cabrera Pérez LC; Padilla-Martínez II; Cruz A; Correa Basurto J; Miliar García Á; Hernández Zavala AA; Gómez López M; Rosales Hernández MC
Mol Divers; 2020 Nov; 24(4):1-14. PubMed ID: 31664610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
